These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 27572863
1. Neuromyelitis optica spectrum disorders in children and adolescents. Tenembaum S, Chitnis T, Nakashima I, Collongues N, McKeon A, Levy M, Rostasy K. Neurology; 2016 Aug 30; 87(9 Suppl 2):S59-66. PubMed ID: 27572863 [Abstract] [Full Text] [Related]
2. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives. Jasiak-Zatonska M, Kalinowska-Lyszczarz A, Michalak S, Kozubski W. Int J Mol Sci; 2016 Mar 02; 17(3):273. PubMed ID: 26950113 [Abstract] [Full Text] [Related]
3. Diagnosis and management of neuromyelitis optica spectrum disorders - An update. Bruscolini A, Sacchetti M, La Cava M, Gharbiya M, Ralli M, Lambiase A, De Virgilio A, Greco A. Autoimmun Rev; 2018 Mar 02; 17(3):195-200. PubMed ID: 29339316 [Abstract] [Full Text] [Related]
4. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, Weinshenker BG, Lucchinetti CF, Pittock SJ. Neurology; 2008 Jan 29; 70(5):344-52. PubMed ID: 18094334 [Abstract] [Full Text] [Related]
5. Neuromyelitis optica. Wingerchuk DM. Int MS J; 2006 May 29; 13(2):42-50. PubMed ID: 16635421 [Abstract] [Full Text] [Related]
11. Neuromyelitis optica: clinical manifestations and neuroimaging features. Sahraian MA, Radue EW, Minagar A. Neurol Clin; 2013 Feb 29; 31(1):139-52. PubMed ID: 23186898 [Abstract] [Full Text] [Related]
12. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies]. Jordan B, Eger K, Kornhuber ME, Zierz S. Fortschr Neurol Psychiatr; 2008 Jan 29; 76(1):21-7. PubMed ID: 18189220 [Abstract] [Full Text] [Related]
13. A comparison of pediatric and adult neuromyelitis optica spectrum disorders: A review of clinical manifestation, diagnosis, and treatment. Baghbanian SM, Asgari N, Sahraian MA, Moghadasi AN. J Neurol Sci; 2018 May 15; 388():222-231. PubMed ID: 29478727 [Abstract] [Full Text] [Related]
14. Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review. Pereira WL, Reiche EM, Kallaur AP, Kaimen-Maciel DR. J Neurol Sci; 2015 Aug 15; 355(1-2):7-17. PubMed ID: 26050520 [Abstract] [Full Text] [Related]
15. Neuromyelitis optica: concept, immunology and treatment. Uzawa A, Mori M, Kuwabara S. J Clin Neurosci; 2014 Jan 15; 21(1):12-21. PubMed ID: 23916471 [Abstract] [Full Text] [Related]
16. Neuromyelitis optica. Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG. Curr Opin Neurol; 2007 Jun 15; 20(3):255-60. PubMed ID: 17495617 [Abstract] [Full Text] [Related]
17. Diagnosis and treatment of neuromyelitis optica. Wingerchuk DM. Neurologist; 2007 Jan 15; 13(1):2-11. PubMed ID: 17215722 [Abstract] [Full Text] [Related]
19. Neuromyelitis optica in a child with atypical onset and severe outcome. Milani N, Zibordi F, Erbetta A, Pollo B, Angelini L. Neuropediatrics; 2004 Jun 15; 35(3):198-201. PubMed ID: 15248104 [Abstract] [Full Text] [Related]
20. Neuromyelitis optica in children: a review of the literature. Derle E, Güneş HN, Konuşkan B, Tuncer-Kurne A. Turk J Pediatr; 2014 Jun 15; 56(6):573-80. PubMed ID: 26388586 [Abstract] [Full Text] [Related] Page: [Next] [New Search]